KBP-201 / British American Tobacco - LARVOL DELTA

KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers (clinicaltrials.gov) - P1/2 | N=101 | Completed | Sponsor: KBio Inc | Active, not recruiting ➔ Completed

Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers (clinicaltrials.gov) - P1/2; N=101; Active, not recruiting; Sponsor: Kentucky BioProcessing, Inc.; Recruiting ➔ Active, not recruiting; N=180 ➔ 101

Clinical • Enrollment change • Enrollment closed • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers (clinicaltrials.gov) - P1/2; N=180; Recruiting; Sponsor: Kentucky BioProcessing, Inc.; Trial completion date: Jul 2022 ➔ Dec 2022; Trial primary completion date: Jul 2021 ➔ May 2022

Clinical • Trial completion date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases

KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers (clinicaltrials.gov) - P1/2; N=180; Recruiting; Sponsor: Kentucky BioProcessing, Inc.; Trial completion date: Mar 2022 ➔ Jul 2022

Clinical • Trial completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • PCR

KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers (clinicaltrials.gov) - P1/2; N=180; Recruiting; Sponsor: Kentucky BioProcessing, Inc.; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases